StockNews.com assumed coverage on shares of XBiotech (NASDAQ:XBIT – Free Report) in a research report released on Thursday. The firm issued a sell rating on the biopharmaceutical company’s stock. XBiotech Stock Performance Shares of XBiotech stock opened at $5.90 on Thursday. XBiotech has a 52-week low of $3.05 and a 52-week high of $6.69. The […]

Related Keywords

Switzerland , Swiss , , Dimensional Fund Advisors , Charles Schwab Investment Management Inc , York Mellon Corp , Xbiotech Inc , Swiss National Bank , Jpmorgan Chase Co , Free Report , National Bank , New York Mellon Corp , Fund Advisors , Charles Schwab Investment Management , Schwab Investment Management , Get Free Report , True Human , Xbiotech , Nasdaq Xbit , Taxbit , Medical , Initiated Coverage , Stocknews Com ,